Home

Johnson & Johnson (JNJ)

177.17
+1.72 (0.98%)
NYSE · Last Trade: Sep 2nd, 3:24 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
These 4 Dividend Stocks Are Money-Printing Machinesfool.com
These companies generate lots of cash to pass on to shareholders.
Via The Motley Fool · August 31, 2025
The Great Rebalancing: Equity Markets Pivot from Tech Giants to Value and Cyclical Stocks
A significant sector rotation is currently underway in equity markets, shifting investor capital away from the mega-cap technology stocks that dominated recent years towards more traditional value and cyclical segments. This trend, gaining significant momentum in 2025, sees sectors such as financial services, basic materials, healthcare, energy, and industrials outperforming,
Via MarketMinute · August 29, 2025
Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Programbenzinga.com
Johnson & Johnson ended a Phase 2a study of nipocalimab in rheumatoid arthritis after no added benefit was seen, but remains confident in its market potential.
Via Benzinga · August 29, 2025
Global Trade Braces for Impact: US-China Tariff Tensions Persist Amidst Fleeting Truces and Escalating Duties
The global economic landscape remains deeply entrenched in a complex and often volatile trade conflict between the United States and China. What began in January 2018 as a series of targeted duties has escalated significantly through 2025, with both nations frequently adjusting and reinstating tariffs, creating a tangled web of
Via MarketMinute · August 28, 2025
Navigating the Tempest: Why Diversification and Active Management are Paramount in Today's Volatile Markets
The global financial markets are currently navigating a tempest of elevated volatility and profound uncertainty, a landscape that has become the new normal for investors worldwide. From persistent geopolitical tensions to unpredictable policy shifts and evolving macroeconomic conditions, the confluence of these factors demands a re-evaluation of traditional investment strategies.
Via MarketMinute · August 27, 2025
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy consumption of AI data centers is putting unprecedented strain on power grids and catalyzing a new wave of investment across traditional and
Via MarketMinute · August 27, 2025
EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Bigbenzinga.com
EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for a boost.
Via Benzinga · August 27, 2025
Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty, the underlying currents suggest continued, albeit slower, economic expansion, particularly within the United States. Investors are keenly watching the interplay
Via MarketMinute · August 27, 2025
The $7 Trillion Question: A Tidal Wave of Capital Poised to Reshape Stock Markets
An unprecedented sum of approximately $7.19 trillion currently sits in money market funds, a colossal reservoir of capital that has captivated the attention of financial strategists worldwide. This monumental accumulation, largely driven by elevated interest rates and a flight to safety, is now seen as a potential catalyst for
Via MarketMinute · August 27, 2025
Inflationary Pressures Persist: Navigating a Slowing Economy and Weakening Labor Market
The United States economy finds itself at a critical juncture in August 2025, grappling with a stubborn inflation problem that continues to defy the Federal Reserve's targets, even as clear signs of an economic slowdown and a weakening labor market emerge. This confluence of factors presents a challenging landscape for
Via MarketMinute · August 26, 2025
As the Market Rotates, This Healthcare ETF Is Leading the Waymarketbeat.com
Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure.
Via MarketBeat · August 26, 2025
Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock with Strong Fundamentalschartmill.com
Discover Johnson & Johnson (JNJ), a top dividend stock with a strong 2.91% yield, consistent growth, and solid financial health for reliable income.
Via Chartmill · August 26, 2025
U.S. Leading Economic Index Dips: A Harbinger of Economic Slowdown or a False Alarm?
The U.S. Leading Economic Index (LEI) has experienced a consistent decline in recent months, sparking concerns about the nation's economic trajectory for the second half of 2025. While the current economic activity, as measured by the Coincident Economic Index (CEI), shows some resilience, the persistent downward trend in the
Via MarketMinute · August 26, 2025
Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cutsmarketbeat.com
Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut.
Via MarketBeat · August 25, 2025
3 Dividend Growth Leaders to Buy Nowdividendstocks.com
Via MarketBeat · August 25, 2025
JNJ Stock Surge Signals Confidence in New Growth Pathmarketbeat.com
Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions.
Via MarketBeat · August 25, 2025
Bridgewater, Once Led By Ray Dalio, Exits Alibaba, JD, PDD And Baidu, Dumping All US-listed Chinese Stocks Amid Geopolitical Risksbenzinga.com
Bridgewater's Q2 filing shows a full exit from Chinese stocks like Alibaba, as new management bets big on NVIDIA & JNJ. See all the shifts.
Via Benzinga · August 25, 2025
Got $500? 3 Dividend Stocks to Buy and Hold Foreverfool.com
If you're looking for income stocks, this trio of healthcare stocks is a great place to start with $500 (or $5,000).
Via The Motley Fool · August 25, 2025
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.fool.com
Growth stocks are dominating the S&P 500, pushing the index's dividend yield to a 25-year low.
Via The Motley Fool · August 24, 2025
2 Dividend Stocks Worth Doubling Down on Right Nowfool.com
These healthcare giants can survive the toughest challenges.
Via The Motley Fool · August 24, 2025
The "Ten Titans" Stocks Now Make Up 38% of the S&P 500. Here's What It Means for Your Investment Portfoliofool.com
Massive growth stocks are driving the performance of the S&P 500, for better or for worse.
Via The Motley Fool · August 24, 2025
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?fool.com
Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF.
Via The Motley Fool · August 23, 2025
Navigating the Peaks and Valleys: A Deep Dive into US Equity Market Valuations
The US equity market in mid-2025 presents a complex and often contradictory landscape for investors. While the S&P 500 has flirted with all-time highs, fueled by optimistic economic data and the anticipation of interest rate adjustments, a closer look reveals a market grappling with elevated valuations, particularly within the
Via MarketMinute · August 22, 2025
U.S. Economy Navigates Divergent Signals: Downward Revisions for 2025 Clash with Stronger Q3 Outlook
The U.S. economy finds itself at a crossroads, grappling with a complex interplay of growth projections. Recent downward revisions for 2025, coupled with a notable contraction in the first quarter of the year, paint a cautious picture. However, this conservative outlook is sharply contrasted by more optimistic signals emanating
Via MarketMinute · August 22, 2025
J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffsjj-com
Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs proposed by the Trump administration.
Via Benzinga · August 22, 2025